2876 - 2900 of 9131 Results
Title
Year
-
OPENTitle: Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assayJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 10Issue #: 5Start Page: 696End Page: 705Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51753Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51753Citation Count: 35
-
OPENTitle: Patterns of TDP‐43 Deposition in Brains with LRRK2 G2019S MutationsJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1541End Page: 1545Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29449Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10524857/pdf/nihms-1899906.pdfCitation Count: 20
- Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analytics2016OPENTitle: Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analyticsJournal Name: mHealthPublisher: AME Publishing CompanyVol: 2Issue #:Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/mhealth.2016.04.02Best OA location URL: https://mhealth.amegroups.com/article/viewFile/10369/pdfCitation Count: 35
-
OPENTitle: Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortiumJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 12Start Page: 1740End Page: 1744Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25600Best OA location URL: http://hdl.handle.net/11573/1383084Citation Count: 41
-
OPENTitle: Nilotinib – Differentiating the Hope from the HypeJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 3Start Page: 519End Page: 522Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-160904Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd160904?id=journal-of-parkinsons-disease%2Fjpd160904Citation Count: 32
-
OPENTitle: The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variantsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 1Start Page: 266.e5End Page: 266.e14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.07.013Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0197458013003187Citation Count: 41
-
OPENTitle: Childhood Stiff-Person Syndrome Improved with RituximabJournal Name: Case Reports in NeurologyPublisher: S. Karger AGVol: 4Issue #: 2Start Page: 92End Page: 96Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000339446Best OA location URL: https://www.karger.com/Article/Pdf/339446Citation Count: 47
- Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's disease2014RESTRICTEDTitle: Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25859Citation Count: 40
- Media hype: Patient and scientific perspectives on misleading medical news2017RESTRICTEDTitle: Media hype: Patient and scientific perspectives on misleading medical newsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1319End Page: 1323Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26993Citation Count: 44
- Biomarkers for Parkinson’s Disease2011RESTRICTEDTitle: Biomarkers for Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 3Issue #: 79Start Page: 79ps14End Page: 79ps14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3002488Citation Count: 42
-
OPENTitle: A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeysJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 39Issue #: 3Start Page: 352End Page: 361Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.05.001Best OA location URL: https://doaj.org/article/63e10c65eb3f433c933e3bf217f2f015Citation Count: 151
- Real-World Experience With VMAT2 Inhibitors2019RESTRICTEDTitle: Real-World Experience With VMAT2 InhibitorsJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 42Issue #: 2Start Page: 37End Page: 41Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000326Citation Count: 50
- Sleep disorders and mortality: A prospective study in the Canadian longitudinal study on aging2023RESTRICTEDTitle: Sleep disorders and mortality: A prospective study in the Canadian longitudinal study on agingJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 114Issue #:Start Page: 128End Page: 136Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2023.12.023Citation Count: 22
- Thalamic deep brain stimulation for drug-induced tremor2015RESTRICTEDTitle: Thalamic deep brain stimulation for drug-induced tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 11Start Page: 1369End Page: 1370Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.033Citation Count: 7
- Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model2009RESTRICTEDTitle: Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson modelJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 219Issue #: 1Start Page: 298End Page: 307Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2009.05.033Citation Count: 93
-
OPENTitle: Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and CognitionJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 75Issue #: 8Start Page: 748End Page: 754Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/jnen/nlw047Best OA location URL: https://academic.oup.com/jnen/article-pdf/75/8/748/33451979/nlw047.pdfCitation Count: 146
-
OPENTitle: Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 119Issue #:Start Page: 105954End Page: 105954Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105954Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10903276/pdf/nihms-1966735.pdfCitation Count: 3
-
OPENTitle: Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorderJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 6Start Page: 1016End Page: 1020Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27385Best OA location URL: http://hdl.handle.net/11380/1205920Citation Count: 41
-
OPENTitle: Patient-centred management of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 887End Page: 888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30359-8Best OA location URL: http://www.thelancet.com/article/S1474442220303598/pdfCitation Count: 2
- Conversational analysis of consciousness during seizures2020RESTRICTEDTitle: Conversational analysis of consciousness during seizuresJournal Name: Epilepsy & BehaviorPublisher: Elsevier BVVol: 112Issue #:Start Page: 107486End Page: 107486Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.yebeh.2020.107486Citation Count: 4
-
OPENTitle: Prospective longitudinal cohort of Argentinean patients with progressive supranuclear palsy and corticobasal syndrome: A platform for epidemiological and translational researchJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100339End Page: 100339Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100339Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100339Citation Count: 0
- The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson’s disease2020RESTRICTEDTitle: The intrinsically restructured fovea is correlated with contrast sensitivity loss in Parkinson’s diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 127Issue #: 9Start Page: 1275End Page: 1283Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-020-02224-9Citation Count: 2
-
OPENTitle: Improved diagnosis of Parkinson's disease from a detailed olfactory phenotypeJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 10Start Page: 714End Page: 721Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.447Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.447Citation Count: 15
- Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors2019RESTRICTEDTitle: Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptorsJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 174Issue #:Start Page: 113788End Page: 113788Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2019.113788Citation Count: 7
-
OPENTitle: Detection of alpha‐synuclein conformational variants from gastro‐intestinal biopsy tissue as a potential biomarker for Parkinson's diseaseJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 44Issue #: 7Start Page: 722End Page: 736Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/nan.12486Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/nan.12486Citation Count: 54